مقارنة فعالية وتحمّل كل من بنزوات البنزيل 25% والبرمترين 5% موضعياً في علاج الجرب لدى البالغين

Authors

  • رولا بدور

Abstract

ـشملت الدراسة 166 مريضاً مصاباً بالجرب من مراجعي العيادة الجلدية الخارجية في مشفى تشرين الجامعي في اللاذقية بين عامي 2014 ـ 2016.

تم تقسيم المرضى إلى مجموعتين: ضمت الأولى 86 مريضاً عولجوا بمستحلب بنزوات البنزيل 25% وضمّت الثانية 80 مريضاً عولجوا بمستحلب البرمترين 25%.

كانت نسب الشفاء متقاربة للدوائين في نهاية العلاج دون فارق هام إحصائياً (P-value=0.079 > 0.05) وكان تحمل البرمترين أفضل من تحمل بنزوزات البنزيل مع فارق هام إحصائياً (P-value = 0 < 0.05)

This study included 166 scabietic Patients attending the outpatient clinic of the Tishreen university hospital at Lattakia from 2014  to 2016. Patients chosen were divided into two groups, the first included 86 Patients and was treated by topical Benzyl benzoate lotion 25%.

the second included 80 Patients and was treated by topical Permethrin lotion 5%.

The efficacy of both of the treatments was approximately the same with better tolerance to Benzyl benzoate than Permethrin with statistically significant correlation (P value<0.05)

Downloads

Published

2018-11-15

How to Cite

1.
بدور ر. مقارنة فعالية وتحمّل كل من بنزوات البنزيل 25% والبرمترين 5% موضعياً في علاج الجرب لدى البالغين. Tuj-hlth [Internet]. 2018Nov.15 [cited 2024Nov.24];40(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/4663

Issue

Vol. 40 No. 4 (2018): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)